As the United States continues to confront the long-term consequences of opioid addiction and chronic pain, biomedical researchers at the State University of New York at Stony Brook are helping advance a potential new...
A novel, non-opioid pain drug candidate originating from research at the State University of New York at Stony Brook has reached a significant milestone.
A compound originally developed at SBU now in clinical development A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study’s...